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a b s t r a c t
Polymyositis is a systemic and idiopathic inflammatory myopathy that, besides muscle 
manifestation, may occur with respiratory involvement, gastrointestinal tract and rarely 
renal involvement. In this latter, there are only two cases of IgA nephropathy, but both in 
dermatomyositis. On the other hand, we reported, for the first time, a case of IgA nephro-
pathy in polymyositis.
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Nefropatia por IgA e polimiosite: uma rara associação
Palavras-chave:
Miopatia inflamatória
Nefropatia por IgA
Polimiosite
Relato de caso
r e s u m o
A polimiosite é uma miopatia inflamatória idiopática sistêmica que, além da manifestação 
muscular, pode eventualmente cursar com acometimento respiratório, do trato gastrintes-
tinal e, raramente, renal. Neste último caso, há descrição de apenas dois casos de nefro-
patia por IgA em pacientes com miopatia, ambos em dermatomiosite. Em contrapartida, 
relatamos pela primeira vez esta rara associação em polimiosite.
© 2014 Sociedade Brasileira de Reumatologia. Publicado por Elsevier Editora Ltda. 
Todos os direitos reservados.
Introduction
Polymyositis is classified within the spectrum of idiopathic 
inflammatory myopathies, together with dermatomyositis. 
It is clinically characterized by progressive proximal muscle 
weakness of the limbs, leading to high morbidity and func-
tional disability.
Among the extramuscular manifestations found, the most 
common are the respiratory and gastrointestinal involvement 
respiratory and of gastrointestinal tract involvement.1,2 Renal in-
volvement in polymyositis is uncommon, with rare descriptions 
of nephropathy associated with acute tubular necrosis second-
ary to rhabdomyolysis and chronic glomerulonephritis.3-9
IgA nephropathy is a primary glomerulonephritis char-
acterized by IgA deposits in the mesangial area of glomeruli. 
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Approximately one-third of patients with this type of renal man-
ifestation progresses to chronic renal failure after 20-25 years 
of disease.10 Among the systemic diseases, IgA nephropathy is 
most commonly associated with Henoch-Schönlein purpura.11 
However, its association with idiopathic inflammatory myopa-
thies is extremely rare, with only two cases described, both in 
dermatomyositis,12,13 which motivated us to present this case.
Clinical case
Male patient, 35 years-old, white, trader, born in São Paulo. 
Previously healthy, presented six months ago with progres-
sive proximal muscle weakness of all four limbs without ap-
parent cause and without constitutional symptoms. When 
the patient came to our hospital service, the physical exami-
nation showed grade III proximal muscle strength in all four 
limbs without skin lesions and/or involvement of other or-
gans, such as lung or kidney. Laboratory tests showed serum 
creatine kinase (CK) = 3,545 IU/L (normal range: 24-204 IU/L), 
aldolase = 33 IU/L (reference value: 7.5 < IU/L), antinuclear fac-
tor and anti-Jo-1 negative, C-reactive protein = 7.8 wg/mL (ref-
erence value: < 5 wg/mL), erythrocyte sedimentation rate = 17 
mm/1st hour (reference value: < 10 mm/1st hour), electroneu-
romyography suggestive of proximal inflammatory myopathy 
of all limbs without evidence of associated neuropathy. The 
muscle biopsy (biceps brachii) revealed the presence of an 
endomysial and perimysial inflammatory infiltrate and also 
necrosis of the muscle fibers and macrophage invasion, thus 
suggesting inflammatory myopathy. During the clinical inves-
tigation, neoplastic and metabolic causes were ruled out.
With the presumptive diagnosis of polymyositis, accord-
ing to the criteria of Bohan and Peter,14 corticosteroids (pred-
nisne 0,5mg/kg/day) and methotrexate (maximum dose 
20 mg/week) were initiated. After six months of treatment, 
the patient developed acute lung injury secondary to pneu-
mopathy requiring endotracheal intubation and mechanical 
ventilation for three weeks. Infection and/or disease activ-
ity were discarded. In face of the possibility of lung disease 
secondary to methotrexate, this medication was discontin-
ued, and the prednisone dose was optimized. The patient 
developed progressive pulmonary improvement without 
sequelae. Subsequently, as a steroid sparing drug, azathio-
prine was introduced (maximum dose of 3 mg/kg/day). Due 
to the stability of the disease and to the pulmonary improve-
ment, the dose of prednisone (which at that time was 0.2 
mg/kg/day) was gradually reduced. However, with no appar-
ent cause the patient began to show macroscopic hematu-
ria, edema of lower limbs (2+/4+) without hemodynamic and 
pressure repercussion. The laboratory examination showed: 
urinalysis with pyuria (> 100 leukocytes/field), hematuria 
(> 100 erythrocytes/field), moderate erythrocyte dysmorphism 
and lipoid casts; 24h-proteinuria = 1.76 g, serum albumin = 3.6 
g/dL, serum creatinine = 0.9 mg/dL and negative urine cul-
ture. There was no sign of clinical-laboratorial activity of PM 
at that time.
We decided then to perform a renal biopsy which showed 
14 glomeruli with diffuse segmental endocapillar cell prolif-
eration. One glomerulus showed one cellular crescent and 
two fibroblastic crescents. Moreover, the glomerulus exhib-
ited mild tubulointerstitial change, focal tubular atrophy and 
interstitial fibrosis. An interlobular artery showed intimal fi-
brosis. Immunofluorescence showed diffuse deposits of only 
IgA in the mesangial region and in the peripheral capillary 
wall of the glomerulus (fig. 1), suggestive of IgA nephropathy. 
The dose of prednisone (0.2 mg/kg/day) was maintained, 
azathioprine was discontinued, and monthly cyclophospha-
mide (0.75 mg/m2, IV) was initiated for 12 months; with the 
patient achieving complete remission of the renal disease. 
disease. Subsequently, as a maintenance drug, azathioprine 
was reintroduced (maximum dose of 2.5 mg/kg/day). Cur-
rently, the patient denotes stability, both from the point of 
view of polymyositis as of nephropathy, and without corti-
costeroid therapy.
Discussion
To our knowledge, this is the first case in the literature that 
reports an IgA nephropathy in idiopathic inflammatory my-
opathy, particularly polymyositis. 
Fig. 1 – Renal biopsy  
(A) Optical microscopy. A glomerulus with diffuse 
proliferative glomerulonephritis. PAS staining,  
(B) Immunofluorescence demonstrating diffuse IgA deposit 
in mesangial region and the peripheral capillary wall of the 
glomerulus.
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Renal involvement in idiopathic inflammatory myopathy 
is uncommon, including acute tubular necrosis and glomeru-
lonephritis.3-9 In the latter case, Takizawa et al.4 demonstrated 
by renal biopsy in a series of 21 cases of dermatomyositis/
polymyositis, that the presence of nephritis was associated 
with membranous and proliferative mesangial glomerulone-
phritis, respectively, in polymyositis and dermatomyositis.
The relationship between IgA nephropathy and idiopathic 
inflammatory myopathies is extremely rare. To date, there are 
only two case reports, both occuring in dermatomyositis.12,13 
Civilibal et al.13 reported a case of newly diagnosed juvenile 
dermatomyositis, with hematuria and nephrotic proteinuria 
in course, without loss of kidney function. A percutaneous re-
nal biopsy allowed the diagnosis of IgA nephropathy. There 
was a favourable response both from the point of view of in-
flammatory myopathy as of nephropathy, with the mainte-
nance of methotrexate associated with oral corticosteroids. 
On the other hand, Yen et al.12 described a young woman who 
developed IgA nephropathy after 1.5 years of an established 
diagnosis of dermatomyositis while using both azathioprine 
and corticosteroids.
Unlike these two cases, in the present trial we present a 
male patient with confirmed diagnosis of polymyositis. How-
ever, like the case reported by Yen et al.,12 the patient had been 
using corticosteroids and immunosuppressive medication, 
when evolved with renal dysfunction after 1.5 years, being 
subsequently diagnosed with IgA nephropathy. 
The association between dermatomyositis and IgA ne-
phropathy is plausible, since both diseases share the involve-
ment of humoral immunity (immunecomplexes).3,15 On the 
other hand, the relationship with polymyositis is remote, be-
cause in the latter case there is a predominance of cellular 
immunity. Thus, in the present clinical case, we strongly sug-
gest the existence of two distinct morbidities.
In short, to our knowledge, we reported for the first time a 
case of IgA nephropathy in a patient with polymyositis.
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